Sinopharm says may be able to make over 1 billion coronavirus vaccine doses in 2021


  • World
  • Tuesday, 20 Oct 2020

Liu Jingzhen, chairman of China National Pharmaceutical Group (Sinopharm), attends a news conference on vaccines for the coronavirus disease (COVID-19), in Beijing, China October 20, 2020. REUTERS/Carlos Garcia Rawlins

BEIJING (Reuters) - China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said on Tuesday.

About 60,000 people have received Chinese coronavirus vaccine candidates during Phase III clinical trials, with no serious side effects reported so far, Tian Baoguo, an official at China's Ministry of Science and Technology, said at the same government media briefing.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

This humanoid robot can now operate with full autonomy
Scientists use AI to help track penguins in Antarctica
Russia launches Soyuz rocket with dozens of satellites, including two from Iran
Windows 10 users will soon have to pay to keep getting security updates
India foreign minister says vandalism of Hindu temples deeply concerning
'Panic buttons', SWAT teams: US braces for election unrest
US states worried about election unrest take security precautions
US arrests Turk for allegedly trying to break Venezuela sanctions
Brazil's Haddad presents fiscal proposals to Lula, but no measures announced
U.S. stocks close lower before election

Others Also Read